BRISTOL MYERS SQUIBB FDA Approval NDA 020152

NDA 020152

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #020152

Documents

Letter1998-03-31
Letter2002-01-08
Letter2003-05-30
Letter2002-06-20
Letter2004-06-01
Letter2005-01-13
Label2005-01-13
Review2007-05-09
Review2007-05-09
Letter2001-03-21
Letter2001-12-04
Review2007-07-06
Review2007-05-09
Review2005-01-06
Review2007-07-06
Other Important Information from FDA2007-05-09
Pediatric Medical Review1900-01-01
Pediatric Written Request1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01

Application Sponsors

NDA 020152BRISTOL MYERS SQUIBB

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004
Discontinued005
Discontinued006

Application Products

001TABLET;ORAL50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1SERZONENEFAZODONE HYDROCHLORIDE
002TABLET;ORAL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1SERZONENEFAZODONE HYDROCHLORIDE
003TABLET;ORAL150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1SERZONENEFAZODONE HYDROCHLORIDE
004TABLET;ORAL200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1SERZONENEFAZODONE HYDROCHLORIDE
005TABLET;ORAL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1SERZONENEFAZODONE HYDROCHLORIDE
006TABLET;ORAL300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1SERZONENEFAZODONE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1994-12-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1996-03-20STANDARD
LABELING; LabelingSUPPL3AP1996-06-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1996-03-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1997-02-06STANDARD
LABELING; LabelingSUPPL6AP2000-07-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1997-01-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1996-12-02STANDARD
LABELING; LabelingSUPPL9AP1997-05-05STANDARD
LABELING; LabelingSUPPL10AP1997-05-05STANDARD
LABELING; LabelingSUPPL11AP1998-03-31STANDARD
LABELING; LabelingSUPPL12AP1997-08-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1999-01-27STANDARD
LABELING; LabelingSUPPL14AP2009-03-13STANDARD
LABELING; LabelingSUPPL15AP2000-06-01STANDARD
LABELING; LabelingSUPPL16AP2000-06-01STANDARD
LABELING; LabelingSUPPL17AP2000-06-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1999-09-23STANDARD
LABELING; LabelingSUPPL19AP2000-06-01STANDARD
LABELING; LabelingSUPPL20AP1999-09-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1999-11-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2000-04-10STANDARD
LABELING; LabelingSUPPL23AP2000-06-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP2000-11-09STANDARD
LABELING; LabelingSUPPL25AP2001-01-23STANDARD
LABELING; LabelingSUPPL26AP2001-03-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL27AP2002-03-11STANDARD
LABELING; LabelingSUPPL28AP2001-12-04STANDARD
LABELING; LabelingSUPPL29AP2002-01-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL30AP2002-04-23STANDARD
LABELING; LabelingSUPPL31AP2003-05-05STANDARD
EFFICACY; EfficacySUPPL32AP2009-03-13PRIORITY
LABELING; LabelingSUPPL33AP2002-06-20STANDARD
LABELING; LabelingSUPPL34AP2004-05-27STANDARD
LABELING; LabelingSUPPL35AP2005-01-12STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL8Null0
SUPPL13Null0
SUPPL18Null0
SUPPL21Null0
SUPPL22Null0
SUPPL24Null0
SUPPL27Null0
SUPPL30Null0
SUPPL32Null8

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20152
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"SERZONE","activeIngredients":"NEFAZODONE HYDROCHLORIDE","strength":"50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"SERZONE","activeIngredients":"NEFAZODONE HYDROCHLORIDE","strength":"100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"SERZONE","activeIngredients":"NEFAZODONE HYDROCHLORIDE","strength":"150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"SERZONE","activeIngredients":"NEFAZODONE HYDROCHLORIDE","strength":"200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"SERZONE","activeIngredients":"NEFAZODONE HYDROCHLORIDE","strength":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"SERZONE","activeIngredients":"NEFAZODONE HYDROCHLORIDE","strength":"300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"01\/12\/2005","submission":"SUPPL-35","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/20152s035lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"SERZONE","submission":"NEFAZODONE HYDROCHLORIDE","actionType":"50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"SERZONE","submission":"NEFAZODONE HYDROCHLORIDE","actionType":"100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"SERZONE","submission":"NEFAZODONE HYDROCHLORIDE","actionType":"150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"SERZONE","submission":"NEFAZODONE HYDROCHLORIDE","actionType":"200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"SERZONE","submission":"NEFAZODONE HYDROCHLORIDE","actionType":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"SERZONE","submission":"NEFAZODONE HYDROCHLORIDE","actionType":"300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2005-01-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.